Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Acta Scientific Neurology
|
March 25, 2025
EEG-Spectra-Guided Personalized rTMS in PTSD with Co-occurring Psychiatric Disorders: A Case Series
Kavya Mohankumar, Siddharth Karthikeya, Shaurya Mahajan, et al.
Psychology Research and Behavior Management
|
December 24, 2021
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management"
Kenneth Blum, Bruce Steinberg, Marjorie C Gondre-Lewis, et al.
Journal of Systems and Integrative Neuroscience
|
September 11, 2018
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic
Kenneth Blum, Edward J Modestino, Marjorie Gondré-Lewis, et al.
Biomedical Journal of Scientific & Technical Research
|
October 30, 2018
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis
Kenneth Blum, Edward J Modestino, Jennifer Neary, et al.
Acta Scientific Neurology
|
August 9, 2024
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
Edward J Modestino, Abdalla Bowirrat, Kai-Uwe Lewandrowski, et al.
Journal of Addiction Psychiatry
|
August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?
Kenneth Blum, Catherine Dennen, Paul R Carney, et al.
International Journal of Environmental Research and Public Health
|
January 11, 2022
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors
Ashim Gupta, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Current Psychopharmacology
|
September 1, 2021
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) <i>via</i> Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Kenneth Blum, Edward J Modestino, David Baron, et al.
Journal of Personalized Medicine
|
April 3, 2021
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration
Kenneth Blum, Shan Kazmi, Edward J Modestino, et al.
Journal of Reward Deficiency Syndrome and Addiction Science
|
July 3, 2018
Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad"
Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Acta Scientific Neurology
|
March 25, 2025
EEG-Spectra-Guided Personalized rTMS in PTSD with Co-occurring Psychiatric Disorders: A Case Series
Kavya Mohankumar, Siddharth Karthikeya, Shaurya Mahajan, et al.
Psychology Research and Behavior Management
|
December 24, 2021
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management"
Kenneth Blum, Bruce Steinberg, Marjorie C Gondre-Lewis, et al.
Journal of Systems and Integrative Neuroscience
|
September 11, 2018
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic
Kenneth Blum, Edward J Modestino, Marjorie Gondré-Lewis, et al.
Biomedical Journal of Scientific & Technical Research
|
October 30, 2018
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis
Kenneth Blum, Edward J Modestino, Jennifer Neary, et al.
Acta Scientific Neurology
|
August 9, 2024
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
Edward J Modestino, Abdalla Bowirrat, Kai-Uwe Lewandrowski, et al.
Journal of Addiction Psychiatry
|
August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?
Kenneth Blum, Catherine Dennen, Paul R Carney, et al.
International Journal of Environmental Research and Public Health
|
January 11, 2022
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors
Ashim Gupta, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Current Psychopharmacology
|
September 1, 2021
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) <i>via</i> Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Kenneth Blum, Edward J Modestino, David Baron, et al.
Journal of Personalized Medicine
|
April 3, 2021
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration
Kenneth Blum, Shan Kazmi, Edward J Modestino, et al.
Journal of Reward Deficiency Syndrome and Addiction Science
|
July 3, 2018
Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad"
Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, et al.
Page
of 7